Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis.
<h4>Background</h4>Lung cancer, particularly non-small-cell lung cancer (NSCLC) is the leading cause of cancer mortality. Chemotherapy combined dendritic cells co-cultured with cytokine-induced killer cells (DC-CIK) immunotherapy has been applied in advanced NSCLC patients' treatmen...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0108958 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849421005367279616 |
|---|---|
| author | Rui-xian Han Xu Liu Pan Pan Ying-jie Jia Jian-chun Yu |
| author_facet | Rui-xian Han Xu Liu Pan Pan Ying-jie Jia Jian-chun Yu |
| author_sort | Rui-xian Han |
| collection | DOAJ |
| description | <h4>Background</h4>Lung cancer, particularly non-small-cell lung cancer (NSCLC) is the leading cause of cancer mortality. Chemotherapy combined dendritic cells co-cultured with cytokine-induced killer cells (DC-CIK) immunotherapy has been applied in advanced NSCLC patients' treatment, but couldn't provide consistent beneficial results. Therefore, it is necessary to evaluate the efficiency and safety of combination therapy to promote the application.<h4>Methods</h4>A literature search for randomized controlled trials of NSCLC was conducted in PubMed database. Before meta-analysis was performed, studies were evaluated heterogeneity. Pooled risk ratios (RRs) were estimated and 95% confidence intervals (CIs) were calculated using a fixed-effect model. Sensitivity analysis was also performed.<h4>Results</h4>Six eligible trials were enrolled. Efficiency and safety of chemotherapy followed by DC-CIK immunotherapy (experimental group) and chemotherapy alone (control group) were compared. 1-year overall survival (OS) (P = 0.02) and progression free survival (PFS) (P = 0.005) in the experimental group were significantly increased compared with the control. Disease control rate (DCR) (P = 0.006) rose significantly in experimental group. However, no significant differences between the two groups were observed in 2-year OS (P = 0.21), 2-year PFS (P = 0.10), overall response rate (ORR) (P = 0.76) and partial response (PR) (P = 0.22). Temporary fever, anemia, leukopenia and nausea were the four major adverse events (AEs) treated by chemotherapy. The incidence of anemia, leukopenia and nausea in the experimental group was obviously lower than the control group. Temporary fever rate was higher in experimental group than that in the control, but could be alleviated by taking sufficient rest.<h4>Conclusions</h4>Chemotherapy combined with DC-CIK immunotherapy showed superiority in DCR, 1-year OS and PFS, and no more AEs appeared, however, there was no significant improvement in ORR, PR, 2-year OS and PFS. As a whole, the combination therapy is safer but modest in efficacy for advanced NSCLC patients. |
| format | Article |
| id | doaj-art-678ec10047f44c868c435bf13b8c99ae |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-678ec10047f44c868c435bf13b8c99ae2025-08-20T03:31:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10895810.1371/journal.pone.0108958Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis.Rui-xian HanXu LiuPan PanYing-jie JiaJian-chun Yu<h4>Background</h4>Lung cancer, particularly non-small-cell lung cancer (NSCLC) is the leading cause of cancer mortality. Chemotherapy combined dendritic cells co-cultured with cytokine-induced killer cells (DC-CIK) immunotherapy has been applied in advanced NSCLC patients' treatment, but couldn't provide consistent beneficial results. Therefore, it is necessary to evaluate the efficiency and safety of combination therapy to promote the application.<h4>Methods</h4>A literature search for randomized controlled trials of NSCLC was conducted in PubMed database. Before meta-analysis was performed, studies were evaluated heterogeneity. Pooled risk ratios (RRs) were estimated and 95% confidence intervals (CIs) were calculated using a fixed-effect model. Sensitivity analysis was also performed.<h4>Results</h4>Six eligible trials were enrolled. Efficiency and safety of chemotherapy followed by DC-CIK immunotherapy (experimental group) and chemotherapy alone (control group) were compared. 1-year overall survival (OS) (P = 0.02) and progression free survival (PFS) (P = 0.005) in the experimental group were significantly increased compared with the control. Disease control rate (DCR) (P = 0.006) rose significantly in experimental group. However, no significant differences between the two groups were observed in 2-year OS (P = 0.21), 2-year PFS (P = 0.10), overall response rate (ORR) (P = 0.76) and partial response (PR) (P = 0.22). Temporary fever, anemia, leukopenia and nausea were the four major adverse events (AEs) treated by chemotherapy. The incidence of anemia, leukopenia and nausea in the experimental group was obviously lower than the control group. Temporary fever rate was higher in experimental group than that in the control, but could be alleviated by taking sufficient rest.<h4>Conclusions</h4>Chemotherapy combined with DC-CIK immunotherapy showed superiority in DCR, 1-year OS and PFS, and no more AEs appeared, however, there was no significant improvement in ORR, PR, 2-year OS and PFS. As a whole, the combination therapy is safer but modest in efficacy for advanced NSCLC patients.https://doi.org/10.1371/journal.pone.0108958 |
| spellingShingle | Rui-xian Han Xu Liu Pan Pan Ying-jie Jia Jian-chun Yu Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis. PLoS ONE |
| title | Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis. |
| title_full | Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis. |
| title_fullStr | Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis. |
| title_full_unstemmed | Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis. |
| title_short | Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis. |
| title_sort | effectiveness and safety of chemotherapy combined with dendritic cells co cultured with cytokine induced killer cells in the treatment of advanced non small cell lung cancer a systematic review and meta analysis |
| url | https://doi.org/10.1371/journal.pone.0108958 |
| work_keys_str_mv | AT ruixianhan effectivenessandsafetyofchemotherapycombinedwithdendriticcellscoculturedwithcytokineinducedkillercellsinthetreatmentofadvancednonsmallcelllungcancerasystematicreviewandmetaanalysis AT xuliu effectivenessandsafetyofchemotherapycombinedwithdendriticcellscoculturedwithcytokineinducedkillercellsinthetreatmentofadvancednonsmallcelllungcancerasystematicreviewandmetaanalysis AT panpan effectivenessandsafetyofchemotherapycombinedwithdendriticcellscoculturedwithcytokineinducedkillercellsinthetreatmentofadvancednonsmallcelllungcancerasystematicreviewandmetaanalysis AT yingjiejia effectivenessandsafetyofchemotherapycombinedwithdendriticcellscoculturedwithcytokineinducedkillercellsinthetreatmentofadvancednonsmallcelllungcancerasystematicreviewandmetaanalysis AT jianchunyu effectivenessandsafetyofchemotherapycombinedwithdendriticcellscoculturedwithcytokineinducedkillercellsinthetreatmentofadvancednonsmallcelllungcancerasystematicreviewandmetaanalysis |